P³LAB
ActiveSummary
The computed 12-month bankruptcy probability of P³LAB is 3.0% (moderate). The annual accounts of P³LAB for financial year 2025 show a net loss of 59% of the equity at the start of that year. The 2025 annual accounts show equity of €978,554 and a net result of -€2.0m. Equity is shrinking by about 13% per year across the filed financial years. Its solvency ranks better than 22% of 143 sector peers (NACE 27, financial year 2025). The company has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals.
Group and network
Holdings and subsidiaries
2 holdingsHoldings 2
Source for every holding own accounts 2025
- NeuroClues.frFRsubsidiaryEquity €440,607Result €281,921100%
- P3Lab Inc.USsubsidiaryEquity -USD 133,429Result -USD 129,424100%
According to the 2025 annual accounts of P³LAB and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Connections & network
7 current directorsThe board mandates are listed below; here you explore them as a network.